BPCR.LSE BioPharma Credit PLC

Financial Services Capital Markets London Exchange
0.9720 USD
Close of Nov 3, 2026
0.8016 0.9860
Market cap
USD 1.09B
P/E
9.7x
P/B
0.96x
ROE
17.7%
Dividend yield
10.12%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is BPCR.LSE undervalued?

Graham number
Price0.9720
Graham value1.51
Discount35.6%

BPCR.LSE trades 35.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioPharma Credit PLC fundamental analysis

No fundamental analysis for BioPharma Credit PLC yet.

BioPharma Credit PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Full company profile